S-1 and CPT-11 plus ramucirumab (IRIS1Rmab) as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: A multicenter phase II study in Japan (N-DOCC-F-C-1701)

被引：0
|
作者：
Kobayashi, K. [1 ]
Morita, M. [1 ]
Ito, S. [1 ]
Inoue, Y. [1 ]
Yamaguchi, I. [1 ]
Kosaka, T. [1 ]
Kuba, S. [1 ]
Sakimura, C. [1 ]
Soyama, A. [1 ]
Adachi, T. [1 ]
Ohno, S. [1 ]
Kobayashi, S. [1 ]
Hara, T. [1 ]
Hidaka, M. [1 ]
Hayashida, N. [1 ]
Yamanouchi, K. [1 ]
Kanetaka, K. [1 ]
Takatsuki, M. [1 ]
Eguchi, S. [1 ]
机构：
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
192TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [1] S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)
    Miyamoto, Yuji
    Tsuji, Akihito
    Tanioka, Hiroaki
    Maekawa, Soichiro
    Kawanaka, Hirofumi
    Kitazono, Masaki
    Oki, Eiji
    Emi, Yasunori
    Murakami, Hidetsugu
    Ogata, Yutaka
    Saeki, Hiroshi
    Shimokawa, Mototsugu
    Natsugoe, Shoji
    Akagi, Yoshito
    Baba, Hideo
    Maehara, Yoshihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (04) : 705 - 712
  • [2] S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)
    Yuji Miyamoto
    Akihito Tsuji
    Hiroaki Tanioka
    Soichiro Maekawa
    Hirofumi Kawanaka
    Masaki Kitazono
    Eiji Oki
    Yasunori Emi
    Hidetsugu Murakami
    Yutaka Ogata
    Hiroshi Saeki
    Mototsugu Shimokawa
    Shoji Natsugoe
    Yoshito Akagi
    Hideo Baba
    Yoshihiko Maehara
    International Journal of Clinical Oncology, 2016, 21 : 705 - 712
  • [3] Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)
    Yuji Miyamoto
    Akihito Tsuji
    Hiroaki Tanioka
    Soichiro Maekawa
    Hirofumi Kawanaka
    Masaki Kitazono
    Eiji Oki
    Yasunori Emi
    Hidetsugu Murakami
    Yutaka Ogata
    Hiroshi Saeki
    Mototsugu Shimokawa
    Shoji Natsugoe
    Yoshito Akagi
    Hideo Baba
    Yoshihiko Maehara
    International Journal of Clinical Oncology, 2018, 23 : 402 - 402
  • [4] S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102) (vol 21, pg 705, 2016)
    Miyamoto, Yuji
    Tsuji, Akihito
    Tanioka, Hiroaki
    Maekawa, Soichiro
    Kawanaka, Hirofumi
    Kitazono, Masaki
    Oki, Eiji
    Emi, Yasunori
    Murakami, Hidetsugu
    Ogata, Yutaka
    Saeki, Hiroshi
    Shimokawa, Mototsugu
    Natsugoe, Shoji
    Akagi, Yoshito
    Baba, Hideo
    Maehara, Yoshihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (02) : 402 - 402
  • [5] Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer
    Sung Yong Oh
    Young-Tae Ju
    Sang-Kyung Choi
    Chang Yoon Ha
    Won Sup Lee
    Hoon Gu Kim
    Gyeong-Won Lee
    Hyuk-Chan Kwon
    Jung Hun Kang
    Investigational New Drugs, 2011, 29 : 1050 - 1056
  • [6] Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer
    Oh, Sung Yong
    Ju, Young-Tae
    Choi, Sang-Kyung
    Ha, Chang Yoon
    Lee, Won Sup
    Kim, Hoon Gu
    Lee, Gyeong-Won
    Kwon, Hyuk-Chan
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 1050 - 1056
  • [7] Phase 1 study of CPT-11 plus S-1 for patients with metastatic gastric cancer
    Tsujinaka, T
    Narahara, H
    Takiuchi, H
    Furukawa, H
    Taguchi, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 426 - 426
  • [8] A phase I trial of CPT-11 and S-1 combination chemotherapy in patients with metastatic colorectal cancer
    Yamaguchi, Yoshiyuki
    Minami, Kazuhito
    Kawabuchi, Yoshiharu
    Ohshita, Akiko
    Hironaka, Katsuji
    HEPATO-GASTROENTEROLOGY, 2008, 55 (82-83) : 407 - 411
  • [9] Phase I/II study of combination therapy with S-1 and CPT-11 for metastatic colorectal cancer
    Nakafusa, Yuji
    Tanaka, Masayuki
    Ohtsuka, Takao
    Miyoshi, Atsushi
    Kohya, Naohiko
    Kitajima, Yoshihiko
    Sato, Seiji
    Mochinaga, Sakiko
    Dohi, Sawako
    Miyazaki, Kohji
    MOLECULAR MEDICINE REPORTS, 2008, 1 (06) : 925 - 930
  • [10] Phase II Study of S-1 Combined with Irinotecan (CPT-11) in Patients with Advanced Colorectal Cancer
    Tsunoda, A.
    Yasuda, N.
    Nakao, K.
    Narita, K.
    Watanabe, M.
    Matsui, N.
    Kusano, M.
    ONCOLOGY, 2009, 77 (3-4) : 192 - 196
12345